Regulatory Models for Biosimilars

14 September 2009 Philadelphia, PA Past Event

Location

Pennsylvania Convention Center
Philadelphia, PA

Agenda

1:30 p.m. – 3:00 p.m.

On Monday, September 14, 2009 Foley Partner David Rosen will participate in a panel presentation at the Regulatory Affairs and Professionals Society (RAPS) 2009 Annual Conference and Exhibition. The panel, “Regulatory Models for Biosimilars,” will brief participants on the progress of pending bills in Congress that may provide a statutory path for biosimilars as the 1984 Hatch-Waxman Act did for drugs. The European regulatory system's approach to generic biologics and techniques for proving bioequivalence with products that appear similar, but present significant variations in immunogenicity will be discussed.

The session leader is Joel Falk, Executive Vice President, The Weinberg Group and also participating on the panel is Sandra Dennis, deputy general counsel for healthcare, Biotechnology Industry Organization (BIO)

To view more details regarding this presentation, please visit the RAPS site

Insights

Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
California Establishes Fund to Combat Wildfire Threats
15 July 2019
Renewable Energy Outlook
There’s No Place Like Home – But Is That a Reasonable Accommodation?
15 July 2019
Labor & Employment Law Perspectives
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ

Regulatory Models for Biosimilars

Location

Pennsylvania Convention Center
Philadelphia, PA

Agenda

1:30 p.m. – 3:00 p.m.